Vaginal News and Research

RSS

Danish study provides new information on hormone replacement therapy and the risk of heart attacks

It's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe's leading cardiology journal, the European Heart Journal today.

30 Sep 2008

24 percent of U.S. women affected by pelvic floor disorders

Nearly 24 percent of U.S. women are affected with one or more pelvic floor disorders, report researchers funded by the National Institutes of Health. Their analysis is the first to document in a nationally representative sample the extent of pelvic floor disorders, a cluster of health problems that causes physical discomfort and limits activity.

17 Sep 2008

Australian men picking HIV up from unsafe sex overseas

A conference in Perth, Australia, has heard that six men in Cairns have contracted HIV after travelling to Papua New Guinea and the news has alarmed health authorities and raised concern that there may be more undetected cases in the area.

17 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

Starpharma, SSL International reach marketing agreement over VivaGel condoms

The Australia-based Starpharma on Tuesday announced that its VivaGel-coated condom will be sold by SSL International, the owner of the Durex condom brand, Bloomberg reports.

11 Sep 2008

VivaGel coated condoms - Starpharma and SSL International in business

Starpharma Holdings Limited has announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel coated condom. SSL manufactures and sells Durex condoms, the market-leading condom brand worldwide.

9 Sep 2008

Vaginal rings provide new HIV protection for women

Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Sexual activities other than intercourse carry risk of HIV, other STIs, study finds

Sexual activities other than intercourse carry some risk of HIV and other sexually transmitted infections, according to a report from the American College of Obstetricians and Gynecologists published recently in the journal Obstetrics and Gynecology, Reuters reports.

4 Sep 2008

Natural birth better for bonding baby and mother

American researchers are suggesting that natural birth may make mothers more responsive to their babies than those who choose to have a Caesarean.

4 Sep 2008

Natural childbirth makes mothers more responsive to own baby-cry

A new study has found that mothers who delivered vaginally compared to caesarean section delivery (CSD) were significantly more responsive to the cry of their own baby, identified through MRI brain scans two to four weeks after delivery.

2 Sep 2008

Coffee appears to protect women from cancer of the uterus

Japanese researchers have discovered a good reason for women to drink coffee - they say it protects them from cancer of the uterus.

2 Sep 2008

Good tidings for women on HRT

For many women struggling to deal with the symptoms of the menopause, the latest research on hormone replacement therapy (HRT) bears good tidings.

25 Aug 2008

Urologists report success using robot-assisted surgery for urinary abnormality

Ashok Hemal, M.D., a urologic surgeon from Wake Forest University Baptist Medical Center, and colleagues have reported success using robot-assisted laparoscopic surgery to repair abnormal openings between the bladder and vagina known as fistulas. Reporting on their experience with seven patients, Hemal and colleagues have the world's largest known success with the procedure.

18 Aug 2008

Maternal deaths following cesarean delivery can be reduced

Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further?

4 Aug 2008

Bacterial vaginosis may increase risk of HIV infection

A common vaginal infection may make women more susceptible to contracting HIV, the virus that causes AIDS, University of North Carolina at Chapel Hill School of Public Health researchers have found.

31 Jul 2008

A dangerous precedent in HIV

Infection with HIV could quadruple in certain populations if people with HIV follow potentially misleading advice contained in a statement from the Swiss Federal Commission for HIV/AIDS, University of New South Wales (UNSW) research warns.

24 Jul 2008

Advanced Cancer Therapeutics licenses technology to develop HPV vaccine

Advanced Cancer Therapeutics (ACT) has announced the signing of two new collaborative agreements that will advance development of the Company's novel human papillomavirus (HPV) vaccine program.

23 Jul 2008

Researchers to compare common ARV as a pill and vaginal gel in unique HIV prevention study

In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.

9 Jul 2008

Pregnancy increases risk of acute myocardial infarction

Although acute myocardial infarction (AMI) is rare in women of child-bearing age, pregnancy can increase a woman's risk of heart attack 3- to 4-fold, according to a study published in the July 15, 2008, issue of the Journal of the American College of Cardiology.

8 Jul 2008

The paradox of anti-HIV vaginal microbicides

With no HIV/AIDS vaccine or cure in sight, vaginal microbicides now in clinical trials are one of the most promising weapons that will protect women against HIV infection. Yet these microbicides could be of more benefit to men than to women, according to a new study co-authored by the University of New South Wales' National Centre in HIV Epidemiology and Clinical Research (NCHECR) and UCLA.

7 Jul 2008